Millenia Hope Acquires Cutting-Edge Biopharma Platform
WILMINGTON, Del., Feb. 17 /PRNewswire-FirstCall/ -- Millenia Hope Inc., a biopharma corporation (OTC Bulletin Board: MLHP - News), is pleased to announce that its Canadian subsidiary, Millenia Hope Biopharma (MH-B), has purchased the Intellectual property, scientific expertise and the research facilities of the former Avance Pharma.
Avance Pharma is one of the world's leading bio-research firms in Phytomic Technology, the commercialization of plant cell cultures. Avance has spent over $30 million in creating its unique technology, including the world's largest collection of highly purified phyto-chemical fractions to be utilized in the pharmaceutical, cosmetic and nutraceutical industry. Because of its cutting-edge technology, Avance Pharma has been the recipient of several R&D grants.
MH-B, retaining Avance's world-class research personnel and all of its operating assets and facilities, is diligently working to complete the initial commercialization of several projects with leading multi-national corporations. These projects will produce immediate revenues, milestone payments and future royalties, based on their specific criteria.
About Millenia Hope:
Millenia Hope develops innovative treatments and quality products that will increase the quality of life, provide tools in the fight against diseases, and promote healthier lives. Our team is committed to research and development to deliver on global medical needs and to bring hope through healthcare solutions.
Safe Harbor Statement:
Certain statements made in this release may contain language describing the plans, goals, strategies, intentions, forecasts and expectations of Millenia Hope that may be referred to as "forward-looking statements." Several important factors could cause actual results to differ materially from those in such forward-looking statements, and Millenia Hope could encounter unanticipated obstacles and delays in developing products, services and markets.
For more information:
Please contact: Mr. Hugo Valente, CFO Tel.: 514-846-5757 or 514-288-8822 http://www.milleniahope.com admin@milleniahope.com
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com
Source: Millenia Hope Inc.